Clinical and immunological consequences of the association between HTLV-1 and strongyloidiasis;Implicações clinicas e imunológicas da associação entre o HTLV-1 e a estrongiloidíase

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 35, Issue 6, 2002, Pages 641-649

  Porto, Maria Aurélia F ^a   Muniz, André ^a   Júnior, Jamary Oliveira ^a   Carvalho, Edgar Marcelino ^a,b  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b Servico de Imunologia do Hosp U   (Brazil)

Author keywords

HTLV 1; Strongyloides stercoralis; Strongyloidiasis

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5;

ANTIBODY RESPONSE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ENDEMIC DISEASE; HELMINTHIASIS; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOLOGY; PARASITE IMMUNITY; RECURRENT INFECTION; REVIEW; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; SUPERINFECTION; TH1 CELL; TROPICS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1; STRONGYLOIDES; STRONGYLOIDES STERCORALIS; VERMES;

EID: 18744433040     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0037-86822002000600016     Document Type: Review

References (67)

1. Abe T, Nawa Y. Worm expulsion and mucosal mast cell response induced by repetitive IL-3 administration in Strongyloides rattiinfected nude mice. Immunology 63: 181-185, 1988.
2. Abe T, Sugaya H, Yoshymura K. Induction of the expulsion of Strangyloidis ratti and retention of Nippostrangyllus brasiliensis in athymic nude mice by repetitive administration of recombinant interleukin-3. Immunology 76: 10-14, 1992.
3. Agapé P, Copin MC, Cavrois M, Panelatti G, Plumelle Y, Ossondo Landeau M. Implication of HTLV-1 infection, strongyloidiasis, and P53 overexpression in the development, response to treatment, and evolution of non-Hodgkin's lymphomas in a endemic area (Martinique, French West Indies). Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 20:394-402, 1999.
4. Ahmad A, Wang CH, Bell RG. A role for IgE in intestinal immunity. Expression of rapid expulsion of Trichinella spiralis in rats transfused with IgE and thoracic duct lymphocytes. The Journal of Immunology 146: 3563-3570, 1991.
5. Arakaki T, Asato R, Ikeshiro T. Is the prevalence of HTLV-1 infection higher in Strongyloides carriers than in non-carriers? Tropical Medical Parasitology 43: 199-200, 1992.
6. Atkins NS, Lindo JF, Lee MG. Immunomodulatory Effects of Concurrent HTLV-I Infection in Strongyloidiasis. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 18: 188-190, 1998.
7. Azimi N, Jacobson S, Leist T, Waldmann T. Involvement of IL-15 in the pathogenesis of Human T Lymphotropic Virus Type I Associated Myelopathy/Tropical spastic Paraparesis: Implications for Therapy with a Monoclonal Antibody directed to the IL-2/15Rb Receptor. The Journal of Immunology 163: 4064-4072, 1999.
8. Azimi N, Nagai M, Jacobson S, Waldmann TA. IL-15 plays a major role in the persistence of Tac-specific CD8 cells in HAM/TSP patients. Proceedings of the National Academy of Science 98: 14559-14564, 2001.
9. Barner M, Mohrs M, Brombacher F, and Kopf M. Differences between IL-4Ra-deficient and IL-4-deficient mice reveal a role for IL-13 in the regulation of Th2 responses. Current Biology 8: 669-672, 1998.
10. Bezjak B. Immunoglobulin Studies in Strongyloidiasis with Special Reference to Raised Serum IgE Levels. The American Journal of Tropical Medicine and Hygiene 24: 945-947, 1975.
11. Biddison WE, Kubota R, Kawanishi T. Human T Cell Leukemia Virus Type I (HTLV-I)-Specific CD8+CTL Clones from Patients with HTLV-I-Associated Neurologic Disease Secrete Proinflammatory Cytokines, Chemokines, and Matrix Metalloproteinase. The Journal of Immunology 159: 2018-2025, 1997.
12. Butterworth AE, Sturrock RF, Houba V. Antibody-dependent cell-mediated damage to schistosomula in vitro. Nature 252: 503-505, 1974.
13. Capron M, Rousseaux J, Mazingue C. Rat Mast Cell-Eosinophil Interaction in Antibody-Dependent Eosinophil Cytotoxicity to Schistosoma mansoni Schistosomula. The Journal of Immunology 121: 2518-2524, 1978.
14. Carvalho EM. Strongyloidiasis. Clinics in Gastroenterology 7: 179-200, 1978.
15. Carvalho EM. Helminthic enteropathies. Baillière's Clinical Tropical Medicine Communicable Diseases 3: 537-565, 1988.
16. Carvalho EM, Bacellar O, Porto MAF, Santos SB, GalvaØo-Castro B, Neva FA. Cytokine profile and immunomodulation in asymptomatic HTLV-1 infected blood donors. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 26:1-6, 2001.
17. Carvalho EM, Gomes MC, Rocha, H. Septicemia por gram negativos em portadores de Estrongiloidíase grave. Revista Médica da Bahia 26: 15-19, 1980.
18. Chieffi PP, Chiattone CS, Feltrim EM, Alves RC. Coinfection by Strongyloides stercoralis in blood donors infected with human Tcell leukemia/lymphoma virus type 1 in São Paulo city, Brazil. Memórias do Instituto Oswaldo Cruz 95: 711-712, 2000.
19. Copeland-Karen FT, Heeney-Jonathan LT. Helper Cell Activation and Human Retroviral Pathogenesis. Microbiological Reviews 60: 722-742, 1996.
20. David JR, Vadas MA, Butterworth AE. Enhanced Helminthotoxic Capacity of Eosinophils from Patients with Eosinophilia. The New England Journal of Medicine 303: 1147-1152, 1980.
21. Dunne DW, Butterworth AE, Fulford AJ, Ouma JH, Sturrock RF. Human IgE responses to Schistosoma mansoni and resistance to reinfection. Memórias do Instituto Oswaldo Cruz 87:99-103, 1992.
22. Farias D, Machado MC, Rodrigues BMC, Campos I, Farias SN, Melo A. HTLV-I/II Infection and Erectile Insufficiency in Bahia, Brazil. AIDS Research and Human Retroviruses 17: S-66, 2001.
23. Finketman FD. Effects of interleukin 12 on immune responses and host protection in mice infected with intestinal nematode parasites. Journal of Experimental Medicine 179: 1563-1572, 1994.
24. Finkelman FD, Donohue TS, goldhill J. Cytokine Regulation of Host Defense Against Parasitic Gastrointestinal Nematodes. Annual Review of Immunology 15: 505-533, 1997.
25. Finkelman FD, Wynn TA. The role of IL-13 in helminth-induced inflammation and protective immunity against nematode infections. Current Opinion of Immunology 11: 420-426, 1999.
26. Galvão CB, Loures L, Rodrigues LGM. Geographic distribution of human T-lymphotropic virus type-1 among blood donors: a Brazilian nationwide study. Transfusion 37: 242, 1997.
27. Genta RM, Douce RW, Walzer PD. Diagnostic Implications of Parasite-Specific Immune Responses in Immunocompromised Patients with Strongyloidiasis. Journal of Clinical Microbiology 23: 1099-1103, 1986.
28. German JC, Flores JH, Chiesura G. Estrongiloidiasis Fatal en Paciente Inmunodeprimido Pos-Transplante Renal. Revista do Hospital das Clínicas da Faculdade de Medicina de São Paulo 47: 31-33, 1992.
29. Goldhill J, Morris SC, Maliszewski C, Urban Jr JF, Funk CD, Finkelman FD, Shea-Donohue T. Interleukin-4 modulates cholinergic neural control of mouse small intestinal longitudinal muscle. American Journal Physiology 272:G1135-G1140, 1997.
30. Gotuzzo E, Terashima A, Alvarez H. Strongyloides stercoralis Hyperinfection Associated with Human T Cell Lymphotropic Virus Type-1 Infection in Peru. The American Journal of Tropical Medicine and Hygiene 60: 146-149, 1999.
31. Hanon E, Hall S, Taylor GP, Saito M, Davis R, Tanaka Y, Usuku K, Osame M, Weber J and Banghan CRM. Abundant Tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type 1 (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood 95: 1386-1392, 2000.
32. Hayashi J, Kishihara Y, Yoshimura E, Furusyo N, Yamaji K, Kawakami T, Murakami H, Kashiwagi S. Correlation between human T cell lymphotropic virus type-1 and Strongyloides stercoralis infections and serum immunoglobulin E responses in residents of Okinawa, Japan. The American Journal of Tropical Medicine and Hygiene 56: 71-75, 1997.
33. Höllsberg P, Hafler DA. Pathogenesis of Diseases Induced by Human Lymphotropic Virus Type I Infection. Seminars in Medicine of the Beth Israel Hospital, Boston 328: 1173-1182, 1993.
34. Kubota R, Kawanishi T, Matsubara H. Demonstration of Human T Lymphotropic Virus Type I (HTLV-I) Tax-Specific CD8+ Lymphocytes Directly in Peripheral Blood of HTLV-I-Associated Myelopathy/ Tropical Spastic Paraparesis Patients by Intracellular Cytokine Detection. The Journal of Immunology 161: 482-488, 1998.
35. Leão RC, Barros MM, Mendes E. Immunological study of hustrongyloidiasis. I. Analysis of IgE levels. Allergology Immunopathology 8: 31-34, 1980.
36. Macchi B, Grelli S, Matteucci C. Human Th1 and Th2 T-cell clones are equally susceptible to infection and immortalization by human T-lymphotropic virus type 1. Journal of General Virology 79: 2469-2474, 1998.
37. Mattos K, Queiroz C, Peçanha-Martins AC. Lymphocyte Alveolitis in HAM/TSP Patients. Arquivos de Neuropsiquiatria 51: 134-136, 1993.
38. Mcrury J, Messias IT, Walzer PD. Specific IgE responses in human strongyloidiasis. Clinical Experimental Immunology 65:631- 638, 1986.
39. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. Definition according to profiles of lymphokine activities and secreted proteins. The Journal of Immunology 136: 2348-2357, 1986.
40. Nakada K, Kohakura M, Komoda H, Hinuma Y. High incidence of HTLV antibody in carriers of Strongyloides stercoralis. Lancet 1: 633, 1984.
41. Nawa Y, Ishikava N, Tsuchiya K. Selective effector mechanisms for the expulsion of intestinal helminths. Parasite Immunology 16: 333-338, 1994.
42. Neva FA, Oliveira J, Gam AA. Interferon-g and Interleukin-4 Responses in Relation to Serum IgE Levels in Persons Infected with Human T Lymphotropic Virus Type I and Strongyloides stercoralis. Journal of Infectious Diseases 178: 1856-1859, 1998.
43. Newton RC, Limpuangthip P, Greenberg S. Strongyloides stercoralis Hyperinfection in a Carrier of HTLV-I Virus With Evidence of Selective Immunosuppression. The American Journal of Medicine 92: 202-207, 1992.
44. O'Doherty MJ, Van de Pette, JE. Nunan TO, Croft DN. Recurrence Strongyloides stercoralis Infection in a Patient with T-Cell Lymphoma-Leukemia. Lancet 1: 858, 1984.
45. Osame M, Usuaki K, Izumo S. HTLV-1 associated myelopathy, a new clinical entity. Lancet 1: 1031-1032, 1986.
46. Ottesen EA, Stanley AM, Gelfand JA. Immunoglobulin and Complement Receptors on Human Eosinophils and Their Role in Cellular Adherence to Schistosomules. The American Journal of Tropical Medicine and Hygiene 26: 134-141, 1977.
47. Pagliuca A. Strongyloides hyperinfection in adult T-cell leukaemia/lymphoma. British Journal of Haematology 105:1, 1999.
48. Patey O, Bouhali R, Breuil J. Arthritis Associated with Strongyloides stercoralis. Scandinavian Journal of Infectious Diseases 22: 233-236, 1990.
49. Patey O, Gessain A, Breuil J, Courillon-Mallet A, Daniel MT, Miclea JM, Roucayrol AM, Sigaux F, Lafaix C. Seven years of recurrent severe strongyloidiasis in an HTLV-I-infected man who developed adult T-cell leukaemia. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 6: 575-579, 1992.
50. Phelps KR, Ginsberg SS, Cinningham AW, Tschachler E, Dosik H. Case report: adult T - cell leukemia/lymphoma associated with recurrent Strongyloides hyperinfection. The American Journal of the Medical Sciences 302: 224-228, 1991.
51. Pires ML, Dreyer G. Revendo a Importância do Strongyloides stercoralis. Revista do Hospital das Clínicas da Faculdade de Medicina de São Paulo 48:175-182, 1993.
52. Plumelle Y, Gonin C, Edouard A, Bucher BJ, Thomas L, Brebion A, Panelatti G. Effect of Strongyloides stercoralis infection and eosinophilia on age at onset and prognosis of adult T-cell leukemia. The American Journal of Clinical Pathology 107: 81-87, 1997.
53. Poltera AA, Katsimbura N. Granulomatous Hepatitis due to Strongyloides Stercoralis. Journal of Pathology 113: 241-245, 1974.
54. Popovic M, Flomenberg N, Volkman DJ. Alleration of T-Cell Functions by Infection with HTLV-I or HTLV-II. Science 226: 459-462, 1984.
55. Porto MAF, Neva FA, Lisboa W, Thompson R, Alcântara L, Carvalho EM. HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis. Parasite Immunology 23: 503-507, 2001.
56. Porto MAF, Oliveira Filho J, Neva FA, Orge G, Alcântara L, Gam A, Carvalho EM. Influence of HTLV-1 infection on the serological and Skin Test for strongyloidiasis. The American Journal of Tropical Medicine Hygiene 65: 610-613, 2001.
57. Robinson RD, Lindo JF, Neva FA, Gam AA, Vogel P, Terry SI, Cooper ES. Immunoepidemiologic studies of Strongyloides stercoralis and human T lymphotropic virus type I infections in Jamaica. Journal of Infectious Diseases 169: 692-696, 1994.
58. Romagnani S. Type 1 T helper and type 2 T helper cells: functions, regulation and role in protection and disease. International Journal of Clinical Laboratory Research 21: 152-158, 1992.
59. Rossi CL, Takahashi EEH, Partel CD. Total Serum IgE and Parasite-Specific IgG and IgA Antibodies in Human Strongyloidiasis. Revista do Instituto de Medicina Tropical de São Paulo 35: 361-365, 1993.
60. Rotman HL, Schnyder-Candrian S, Scott P, Nolan TJ, Schad G.A, Abraham D. IL-12 eliminates the Th-2 dependent protective immune response of mice to larval Strongyloides stercoralis. Parasite Immunology 19:29-39, 1997.
61. Sato Y, Shiroma Y. Concurrent Infections with Strongyloides and T-Cell Leukemia Virus and Their Possible Effect on Immune Responses of Host. Clinical Immunology and Immunopathology 52: 214-224, 1989.
62. Sato Y, Shiroma Y, Kiyuna S, Toms H, Kobayashi J. Reduced efficacy of chemotherapy might accumulate concurrent HTLV-I infection among strongyloidiasis patients in Okinawa, Japan. Transactions of the Royal Society Tropical Medicine and Hygiene 88: 59, 1994.
63. Shikiya K, Zaha O, Niimura S, Uehara T, Ohshiro J, Kinjo F, Saito A, Asato R. Clinical study on ivermectin against 125 strongyloidiasis patients. Kansenshogaku Zasshi 68: 13-20, 1994.
64. Takai A, Uesato H, Nakama T, Sato Y. Otsuru, M. Jpn. J. Parasitol., 33:33, 1984.
65. Apud: Sato Y. & Shiroma Y. Concurrent Infections with Strongyloides and T-Cell Leukemia Virus and Their Possible Effect on Immune Responses of Host. Clinical Immunology and Immunopathology 52: 214-224, 1989.
66. Tendler CL, Greenberg SJ, Blatner WA, Mann A, Murphy E, Fleisher T, Hanchard B, Morgan O, De Burton J, Nelson DL, Waldmann T. Transactivation of interleukin 2 and its receptor induces immune activation of human T-cell lymphotropic virus type I associated myelopathy: pathogenic implications and a rationale for immunotherapy. Proceedings of the National Academy of Science, USA 87: 5218-5222, 1990.
67. Uchiyama T, Hori T, Tsudo M, Wano Y, Umadome H, Tamori S, Yodoi J, Maeda M, Sawami H, Uchino H. Interleukin-2 receptor (Tac antigen) expressed on adult T-cell leukemia cells. Journal of Clinical Investigation 76: 446-453, 1985.